β 2-adrenoceptors, NADPH oxidase, ROS and p38 MAPK: Another 'radical' road to heart failure?

British Journal of Pharmacology

Volumn 162, Issue 5, 2011, Pages 1009-1011

  Di Lisa, Fabio ^a,b   Kaludercic, Nina ^a   Paolocci, Nazareno ^c,d  

^a UNIVERSITY OF PADOVA   (Italy)

^b CNR   (Italy)

^c DEPARTMENT OF PATHOLOGY   (United States)

^d UNIVERSITY OF PERUGIA   (Italy)

Author keywords

1 2 adrenoceptor; congestive heart failure; oxidative stress

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ADRENERGIC ACTIVITY; APOPTOSIS; CONGESTIVE HEART FAILURE; DISEASE COURSE; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME LOCALIZATION; HEART HYPERTROPHY; HEART INFARCTION; HEART MUSCLE FIBROSIS; HUMAN; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; DISEASE MODEL; GENETICS; HEART FAILURE; METABOLISM; MOUSE; NOTE; TRANSGENIC MOUSE;

ANIMALS; DISEASE MODELS, ANIMAL; HEART FAILURE; HUMANS; MICE; MICE, TRANSGENIC; NADPH OXIDASE; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REACTIVE OXYGEN SPECIES; RECEPTORS, ADRENERGIC, BETA-2; SIGNAL TRANSDUCTION;

EID: 79551476911     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.01130.x     Document Type: Review

References (16)

1. Ahmet I, Morrell C, Lakatta EG, Talan MI, (2009). Therapeutic efficacy of a combination of a beta1-adrenoreceptor (AR) blocker and beta2-AR agonist in a rat model of postmyocardial infarction dilated heart failure exceeds that of a beta1-AR blocker plus angiotensin-converting enzyme inhibitor. J Pharmacol Exp Ther 331: 178-185.
2. Au DH, Udris EM, Fan VS, Curtis JR, McDonell MB, Fihn SD, (2003). Risk of mortality and heart failure exacerbations associated with inhaled beta-adrenoceptor agonists among patients with known left ventricular systolic dysfunction. Chest 123: 1964-1969.
3. Canton M, Menazza S, Sheeran FL, Polverino de Laureto P, Di Lisa F, Pepe S, (2010). Oxidation of myofibrillar proteins in human heart failure. J Am Coll Cardiol (in press).
4. Diwan A, Dorn GW, (2007). Decompensation of cardiac hypertrophy: cellular mechanisms and novel therapeutic targets. Physiology (Bethesda) 22: 56-64.
5. Du XJ, Autelitano DJ, Dilley RJ, Wang B, Dart AM, Woodcock EA, (2000). beta(2)-adrenergic receptor overexpression exacerbates development of heart failure after aortic stenosis. Circulation 101: 71-77.
6. Heusch P, Canton M, Aker S, van de Sand A, Konietzka I, Rassaf T, et al. (2010). The contribution of reactive oxygen species and p38 mitogen-activated protein kinase to myofilament oxidation and progression of heart failure in rabbits. Br J Pharmacol 160: 1408-1416.
7. Kaludercic N, Carpi A, Menabo R, Di Lisa F, Paolocci N, (2010a). Monoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia/reperfusion injury. Biochim Biophys Acta DOI:10.1016/j.bbamcr.2010.09. 010.
8. Kaludercic N, Takimoto E, Nagayama T, Feng N, Lai EW, Bedja D, et al. (2010b). Monoamine oxidase A-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload. Circ Res 106: 193-202.
9. Kuroda J, Sadoshima J, (2010). NADPH oxidase and cardiac failure. J Cardiovasc Transl Res 3: 314-320.
10. Liggett SB, Tepe NM, Lorenz JN, Canning AM, Jantz TD, Mitarai S, et al. (2000). Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts: critical role for expression level. Circulation 101: 1707-1714.
11. Matera MG, Martuscelli E, Cazzola M, (2010). Pharmacological modulation of beta-adrenoceptor function in patients with coexisting chronic obstructive pulmonary disease and chronic heart failure. Pulm Pharmacol Ther 23: 1-8.
12. Milano CA, Allen LF, Rockman HA, Dolber PC, McMinn TR, Chien KR, et al. (1994). Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor. Science 264: 582-586.
13. Rockman HA, Koch WJ, Lefkowitz RJ, (2002). Seven-transmembrane-spanning receptors and heart function. Nature 415: 206-212.
14. Ryall JG, Schertzer JD, Murphy KT, Allen AM, Lynch GS, (2008). Chronic beta2-adrenoceptor stimulation impairs cardiac relaxation via reduced SR Ca2+-ATPase protein and activity. Am J Physiol Heart Circ Physiol 294: H2587-H2595.
15. Xu Q, Dalic A, Fang L, Kiriazis H, Ritchie R, Sim K, et al. (2010). Myocardial oxidative stress contributes to transgenic beta2-adrenoreceptor activation-induced cardiomyopathy and heart failure. Br J Pharmacol 162: 1012-1028.
16. Zhang M, Brewer AC, Schroder K, Santos CX, Grieve DJ, Wang M, et al. (2010). NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis. Proc Natl Acad Sci U S A 107: 18121-18126.